Press Releases

BeiGene Appoints Dr. Ji Li as Executive Vice President, Global Head of Business Development    read more...

BeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting    read more...

BeiGene Appoints Eric Hedrick, M.D. as Interim Chief Medical Officer    read more...

BeiGene Announces Closing of Its Initial Public Offering    read more...